Urovant Sciences Appoints James Robinson to its Board of Directors
IRVINE, Calif. & BASEL, Switzerland--(BUSINESS WIRE)--Mar 6, 2019--Urovant Sciences (Nasdaq: UROV), a clinical-stage biopharmaceutical company focused on developing and commerciali…
IRVINE, Calif. & BASEL, Switzerland--(BUSINESS WIRE)--Mar 6, 2019--Urovant Sciences (Nasdaq: UROV), a clinical-stage biopharmaceutical company focused on developing and commerciali…